Literature DB >> 9519062

Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies.

S M Lawrie1, S S Abukmeil.   

Abstract

BACKGROUND: Numerous in vivo brain imaging studies suggest that cerebral structure is abnormal in schizophrenia, but implicate different regions to varying extents.
METHOD: We identified published MRI studies in schizophrenia with searches of the computerised literature and key journals. Reports giving the volumes of cortical structures in people with schizophrenia and controls were included. The percentage differences in volumes were calculated and the median taken as a summary measure for each brain region.
RESULTS: Forty relevant studies were identified. The median percentage volume differences revealed overall reductions in the whole brain (3%), temporal lobe (6% left, 9.5% right), and the amygdala/ hippocampal complex (6.5%, 5.5%); and increases in the lateral ventricles (44%, 36%), that were greatest in the body and occipital horns. Segmentation studies suggest that grey matter is reduced but that white matter volumes may actually be increased. In men, substantial reductions were also evident in the amygdala and hippocampus, as well as the largest reductions of all in the parahippocampus (14%, 9%). Few studies gave figures for women alone.
CONCLUSIONS: Several brain structures in schizophrenia are affected to a greater extent than expected from overall reductions in brain volume. Further studies are required in affected women, and to try to identify clinical and aetiological associations of these findings.

Entities:  

Mesh:

Year:  1998        PMID: 9519062     DOI: 10.1192/bjp.172.2.110

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  143 in total

1.  Volumetric magnetic resonance imaging study of the brain in subjects with sex chromosome aneuploidies.

Authors:  M M Warwick; G A Doody; S M Lawrie; J N Kestelman; J J Best; E C Johnstone
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-05       Impact factor: 10.154

2.  BrainImageJ: a Java-based framework for interoperability in neuroscience, with specific application to neuroimaging.

Authors:  Y R Ng; S Shiffman; T J Brosnan; J M Links; L S Beach; N S Judge; Y Xu; U V Kelkar; A L Reiss
Journal:  J Am Med Inform Assoc       Date:  2001 Sep-Oct       Impact factor: 4.497

3.  Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia.

Authors:  P M Thompson; C Vidal; J N Giedd; P Gochman; J Blumenthal; R Nicolson; A W Toga; J L Rapoport
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

4.  Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats.

Authors:  J A Rosenkranz; A A Grace
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

Review 5.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

Review 6.  [Mrt-based morphometry. A current assessment].

Authors:  M Tittgemeyer; D Y von Cramon
Journal:  Nervenarzt       Date:  2004-12       Impact factor: 1.214

7.  Method for bias field correction of brain T1-weighted magnetic resonance images minimizing segmentation error.

Authors:  Juan D Gispert; Santiago Reig; Javier Pascau; Juan J Vaquero; Pedro García-Barreno; Manuel Desco
Journal:  Hum Brain Mapp       Date:  2004-06       Impact factor: 5.038

Review 8.  The environment and susceptibility to schizophrenia.

Authors:  Alan S Brown
Journal:  Prog Neurobiol       Date:  2010-10-16       Impact factor: 11.685

Review 9.  Prevention of schizophrenia: can it be achieved?

Authors:  Cheng Lee; Thomas H McGlashan; Scott W Woods
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

10.  Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation.

Authors:  Rabia Nazik Yüksel; Neslihan Altunsoy; Baise Tikir; Merve Cingi Külük; Kubranur Unal; Sema Goka; Cigdem Aydemir; Erol Goka
Journal:  Ther Adv Psychopharmacol       Date:  2014-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.